Compounds > aldosterone
Page last updated: 2024-11-07

aldosterone and Prostatic Neoplasms, Castration-Resistant

aldosterone has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Seale, KN1
Labriola, MK1
Jiang, XS1
Armstrong, A1

Other Studies

1 other study available for aldosterone and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma.
    BMJ case reports, 2022, Oct-05, Volume: 15, Issue:10

    Topics: Abiraterone Acetate; Adrenalectomy; Aldosterone; Androgens; Androstenes; Humans; Male; Nitriles; Pro

2022